HUM vs MGX · P/E 39, rev $129.66B vs rev $52.3M
Humana Inc (HUM) versus Metagenomi, Inc. Common Stock (MGX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MGX revenue for 2024-12-31 was $52.3M. Net income was -$78.1M. Revenue was up 16.8% from 2023-12-31 to 2024-12-31. MGX currently screens at market cap $44.4M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MGX currently screens at market cap $44.4M.
Not investment advice. Open the HUM and MGX stock pages for the full models.
Not investment advice.